MYndspan is pioneering the future of preventive brain health by offering clinical-grade MEG (magnetoencephalography) scanning and validated metrics to provide clear, objective insights into brain function. Their mission is to end preventable neurodegeneration through early detection and to give people the tools to understand and monitor their brain health with clinical precision.

They are the first company to offer advanced MEG technology directly to consumers, starting with their flagship scanning site in London. MYndspan empowers individuals to take control of their brain health by monitoring brain function over time and detecting cognitive decline early.

MYndspan aims to close the gap in brain health awareness, as poor brain health is the world's leading cause of disability and most people remain unaware of their brain functionality until symptoms arise. The company is dedicated to making advanced brain health assessments accessible outside of research labs and driving early intervention to prevent neurodegenerative diseases.

Their research and technology are backed by over 300 peer-reviewed MEG studies and trusted by institutions such as Oxford and Cambridge. MYndspan is building a global network of scanning sites to support personalized brain health monitoring and intervention.